+987.9%
MRNA vs BROS
-18.6%
+1,006.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BROS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.9% | +12.2% | +12.7% |
| 7D | +20.6% | +2.5% | +18.2% | +19.3% |
| 30D | +27.1% | +15.1% | +12.1% | +18.7% |
| 3M | +353.4% | -31.4% | +384.8% | +413.1% |
| 6M | +446.3% | -22.6% | +468.9% | +500.7% |
| YTD | +776.2% | -28.1% | +804.3% | +890.3% |
| 1Y | +987.9% | -20.3% | +1,008.2% | +1,088.9% |
| All | +987.9% | -18.6% | +1,006.5% | +1,088.9% |
Cumulative growth
Daily Returns
Daily percentage return beside BROS.
Daily Out/Under-Performance
Portfolio return minus BROS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BROS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BROS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling